ArticlePloS one2026

3D CNN-CVAE and LSTM-guided de novo design of rotigotine derivatives targeting dopamine D1 and D3 receptors in restless legs syndrome.

Sinan Eliaçık et al.PubMed ↗Publisher ↗

No numbers read from the abstract.